Anti-infective antibodies: Finding the path forward

Article Abstract:

Basel-based Novartis Pharmaceuticals, in its quest to find new weapons to fight infections, has paid $569 million to acquire NeuTec Pharmaceuticals of Manchester, UK, and its two late-stage products, both antibody fragments developed as therapies for difficult-to-treat microbes. NeuTec's anti-staph product, Aurograb is an antibody fragment mAb rather than a polyclonal antibody and binds to the staphylococcal ABC transporter, a drug-efflux pump and if Aurograb is successful it might boost more than Novartis's profit.

Product development, Acquisitions & mergers, Sales, profits & dividends, Pharmaceutical preparations, United Kingdom, Mergers, acquisitions and divestments, Company acquisition/merger, Switzerland, Company sales and earnings, Company earnings/profit, Viral antibodies, Antibodies, NeuTec Pharma, Novartis Pharma AG

---

Survey finds 136 medicines in testing for infectious diseases

Article Abstract:

A new survey conducted by the Pharmaceutical Research and Manufacturers of America (PhRMA) has revealed that 136 new medicines against infectious diseases are being tested by pharmaceutical and biotechnology firms. PhRMA Pres Alan F. Holmer said these medicines and vaccines undergoing clinical trials represent hope for reducing the threat posed by infectious diseases, which are the world's leading cause of death. Medicines under development include 42 vaccines, 27 antibiotics and 31 antivirals.

Infection, Biotechnology industry, Biotechnology industries, Surveys, Drug therapy, Communicable diseases, Pharmaceutical Research and Manufacturers of America

---

Letting antibodies get to your head

Article Abstract:

The disaster caused by streptococcal sugar in Sydenhum chorea is illustrated. The cross-reaction of antibodies was elevated in sera and cerebrospinal fluid during acute Sydenhum chorea.

United States, Analysis, Complications and side effects, Rheumatic fever, Chorea

Similar abstracts:

• Abstracts: The cost-effectiveness of immunization. Paying the price for one's beliefs. A price worth paying
• Abstracts: CAn diversity training move them up? Comfortable shoes! Here's how to find them. Don't call them Rollerbladers
• Abstracts: An atypical variant of Fabry's disease in men with left ventricular hypertrophy. Left ventricular assist device and drug therapy for the reversal of heart failure
• Abstracts: Healing by design. Care of the potential organ donor. Wound healing with electric potential
• Abstracts: Effect of iodophor vs iodine tincture skin preparation on blood culture contamination rate. New blood cancer therapies under study

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.